Evidence map›Paper›PMID 32235621›Full record

ArticleMolecules (Basel, Switzerland)2020

Green Synthesis of an Activated Carbon-Supported Ag and ZnO Nanocomposite for Photocatalytic Degradation and Its Antibacterial Activities.

Amel Taha, Melek Ben Aissa, Enshirah Da'na

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Catalytic Reduction of p-Nitrophenol on MnONanomaterials (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Facile Green Synthesis of Ni(OH)Molecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amel TahaDepartment of Chemistry, King Faisal University, Alahsa 31982, Saudi Arabia.ORCID 0000-0002-6247-3925
Melek Ben AissaCommunity College in Albuqaiq, King Faisal University, 31992, Saudi Arabia.ORCID 0000-0002-1978-8497
Enshirah Da'naBiomedical Engineering Department, King Faisal University, Alahsa 31982, Saudi Arabia.ORCID 0000-0003-0110-973X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study Ag nanoparticles (AgNPs), ZnO nanoparticles (ZnONPs), and Ag/ZnO nanocomposites were greenly synthesized and loaded on activated carbon via three different routes: simple impregnation, successive precipitation, and co-precipitation. Neem leaf extract was used as a reducing and stabilizing agent. The morphological and structural properties of the synthesized nanocomposites have been examined using different analytical techniques such as XRD, SEM, FTIR, and UV. The antibacterial and catalytic activity of the synthesized nanocomposites were examined and compared. The results showed that AgNPs loaded on activated carbon (Ag/AC) has the best catalytic activity compared to the other nanocomposites, which is attributed to the good dispersal of AgNPs on the surface of activated carbon. Furthermore, AgNPs showed the best antibacterial effect on eight out of 16 tested pathogens. Results also showed that the order of precipitation is an important factor, as both antibacterial activities and photodegradation activities were higher for ZnO/Ag/AC than Ag/ZnO/AC. Furthermore, the co-precipitation method was shown to be better than the successive precipitation method for 4-nitrophenol photodegradation and 14 out of the 16 antibacterial tests performed.

Indexed as

Anti-Bacterial AgentsGreen Chemistry TechnologyPhotochemical ProcessesNanocompositesSilverZinc OxideAnti-Bacterial AgentsSilverZinc Oxideactivated carbonantibacterialcatalytic activitygreen synthesisnanocompositeneem leaf extract

Identifiers

PMID32235621
PMCPMC7180850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.